NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/07/2024
Back to search
Official data from USPTO
FERNDALE LABORATORIES INC ETHICAL PHARMACEUTICALS SINCE 1897
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
02/07/2024
Trademark type
Combined
Nice classes
5
Filing date
01/04/2000
Registration date
09/02/2003
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2024
Last transaction
02/07/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/16/2001
First use in commerce
07/16/2001
Drawing code
3
Owner type
03
Owner location
FERNDALE, MI, US
Examiner
FISHER, HANNAH
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
FERNDALE IP, INC.
Ferndale Laboratories, Inc.
Representatives
Julie A. Greenberg Fishman Stewart PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
TOPICAL GEL FOR MEDICAL AND THERAPEUTIC USEPREPARATIONS FOR TREATING PRESSURE SORESCAPSULES FOR ALLERGY RELIEF AND ADHESIVE BANDAGES AND/OR MEDICAL ADHESIVE TAPE
Publications
History of USPTO decisions and trademark events.
44 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02/07/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/07/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/06/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/10/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/02/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/21/2018
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/04/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/03/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/03/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/03/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
02/19/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/13/2009
PLGL
ASSIGNED TO PARALEGAL
01/07/2009
E815
TEAS SECTION 8 & 15 RECEIVED
01/05/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/03/2007
CFIT
CASE FILE IN TICRS
07/05/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/23/2005
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2003
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/27/2003
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/12/2003
EX2G
SOU EXTENSION 2 GRANTED
06/12/2003
REIN
REINSTATED
04/10/2003
EXT2
SOU EXTENSION 2 FILED
12/23/2002
EEXT
SOU TEAS EXTENSION RECEIVED
12/23/2002
EX1G
SOU EXTENSION 1 GRANTED
12/22/2002
ABN6
ABANDONMENT - NO USE STATEMENT FILED
10/31/2002
DPCC
DIVISIONAL PROCESSING COMPLETE
07/07/2002
EXT1
SOU EXTENSION 1 FILED
06/25/2002
IUAF
USE AMENDMENT FILED
06/20/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2002
DRRR
DIVISIONAL REQUEST RECEIVED
06/20/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2002
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/25/2001
PUBO
PUBLISHED FOR OPPOSITION
10/02/2001
NPUB
NOTICE OF PUBLICATION
09/12/2001
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2001
CNFR
FINAL REFUSAL MAILED
03/20/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2000
CNRT
NON-FINAL ACTION MAILED
06/19/2000
DOCK
ASSIGNED TO EXAMINER
06/07/2000
Continuous trademark protection
Get notified about every new filing that threatens FERNDALE LABORATORIES INC ETHICAL PHARMACEUTICALS SINCE 1897 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.